Skip to Content


In the US, Moexipril (moexipril systemic) is a member of the drug class Angiotensin Converting Enzyme Inhibitors and is used to treat Diabetic Kidney Disease, Heart Attack, Heart Failure, High Blood Pressure and Left Ventricular Dysfunction.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antihypertensive agent

ACE inhibitor (angiotensin-converting enzyme inhibitor)

Chemical Name

(3S)-2-[(2S)-N-[(1S)-1-Carboxy-4-phenylpropyl]alanyl]-1,2,3,4-tetrahydro-6,7-dimetoxy-3-isoquinolinecarboxylic acid, 2-etyl ester

Foreign Names

  • Moexiprilum (Latin)
  • Moexipril (German)
  • Moexipril (French)
  • Moexipril (Spanish)

Generic Names

Brand Names

  • Perdix
    Schwarz Pharma, Lebanon
  • Uniretic (Moexipril and Hydrochlorothiazide)
    Adeka, Turkey
  • Enulid 15 (Moexipril and Hydrochlorothiazide)
    Rottapharm, Italy
  • Femipres
    UCB Pharma, Italy
  • Femipres plus (Moexipril and Hydrochlorothiazide)
    UCB Pharma, Italy
  • Fempress
    Actavis, Germany
  • Fempress plus (Moexipril and Hydrochlorothiazide)
    Actavis, Germany
  • Moex
    Schwarz, Lithuania; UCB, Bulgaria; UCB, Czech Republic; UCB Pharma, France
  • Perdix
    Schwarz, Oman; UCB Pharma, United Kingdom
  • Primox
    Schwarz, Egypt
  • Primox Plus (Moexipril and Hydrochlorothiazide)
    Schwarz, Egypt
  • Renoprotec
    Merck, Mexico
  • Uniretic (Moexipril and Hydrochlorothiazide)
    UCB, United States
  • Univasc
    Adeka, Turkey; UCB, United States


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.